Enzyme-mediated gene writing

Our core technology is based on engineered terminal deoxynucleotidyl transferases (TdT) to enable the production of gene and genome libraries. Our TdT enzymes are proven to quantitatively incorporate a wide variety of reversibly terminating nucleotide triphosphates of all four nucleobases. 

Hear from key opinion leaders from the industry

Nuclera's technology represents fresh approaches, which will improve cost and quality very significantly.

George Church, Professor, Harvard and MIT

Want to know more about our mission to change synthetic biology?

Our mission is simple: provide high-quality genes and proteins at your benchtop

Get in touch